Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus.
D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D004558:Electric Stimulation; D005154:Facial Nerve / Q000187:drug effects*; D008297:Male; D009046:Motor Neurons / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*; D011985:Receptors, Serotonin / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology / Q000502:physiology*; D013997:Time Factors
D000928:Antidepressive Agents; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D011985:Receptors, Serotonin; D012701:Serotonin; D009638:Norepinephrine